Cost-effectiveness of diagnostic testing strategies including cervical-length measurement and fibronectin testing in women with symptoms of preterm labor

G. -J. van Baaren*, J. Y. Vis, F. F. Wilms, M. A. Oudijk, A. Kwee, M. M. Porath, H. C. J. Scheepers, M. E. A. Spaanderman, K. W. M. Bloemenkamp, M. C. Haak, C. J. Bax, J. M. J. Cornette, J. J. Duvekot, B. W. A. Nij Bijvanck, J. van Eyck, M. T. M. Franssen, K. M. Sollie, F. P. H. A. Vandenbussche, M. Woiski, A. C. BolteJ. A. M. van der Post, P. M. M. Bossuyt, B. C. Opmeer, B. W. J. Mol

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)596-603
Number of pages8
JournalUltrasound in Obstetrics & Gynecology
Volume51
Issue number5
DOIs
Publication statusPublished - 1 May 2018

Keywords

  • cervical length
  • economic evaluation
  • fetal fibronectin
  • preterm labor
  • ANTENATAL CORTICOSTEROIDS
  • BIRTH
  • NIFEDIPINE
  • CHILDHOOD
  • OUTCOMES
  • TRIAL
  • RISK

Cite this